Search

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

In this webinar we will look in depth at the Xcellerex™ magnetic mixer, designed to deliver high performance for even the most challenging large-scale single-use mixing applications.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Continuous processing for small molecule products has been a hot topic for years, but where does the industry stand with it today?

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

A look back at some of the most inspiring quotes from our interviews.

From developments in cell culture media to enhancing the potency of monoclonal antibodies – check out our free eBook.

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.